STAAR Surgical 1Q26: Early Signs Of A Durable Turnaround (NASDAQ:STAA)
· seekingalpha.com
STAAR Surgical Company delivered a robust 1Q26 beat, with revenue up 119% YoY to $93.5M and a swing to $5.2M net income. See why STAA stock is a buy.
I hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensiv...